First-in-human study of dual-imaging catheter to assess heart attack risk, guide treatment
Researchers at the UC Davis National Center for Interventional Biophotonic Technologies (NCIBT) have concluded the first-in-human test of a new device that could help doctors better detect and treat atherosclerosis, the narrowing of blood vessels due to plaque buildup. The flexible catheter-based device, developed at NCIBT labs, is designed to navigate the interior walls of arteries and capture…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Diverse social activities may help slow age-related cognitive decline
United Kingdom
-
Takara Bio USA partners with SPT Labtech to deliver automation-ready NGS library preparation technologies
United Kingdom
-
Pure cranberry juice may help protect teeth from decay
United Kingdom
-
ScionxBio announces collaboration to develop long-acting xRNA therapeutics
United Kingdom
-
Combination approach slows osteosarcoma growth and prolongs survival in preclinical models
United Kingdom
-
CT scans reveal body composition changes preceding pancreatic cancer diagnosis
United Kingdom
-
Alzheimer’s biomarkers may help predict disease progression in ALS
United Kingdom
-
Paternal age may influence sex-specific gene expression changes in embryos
United Kingdom